123 related articles for article (PubMed ID: 21606425)
1. Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?
Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
J Clin Oncol; 2011 Jun; 29(18):e553-4; author reply e555-6. PubMed ID: 21606425
[No Abstract] [Full Text] [Related]
2. Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Atkins CD
J Clin Oncol; 2014 Oct; 32(29):3341. PubMed ID: 25135996
[No Abstract] [Full Text] [Related]
3. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.
Hochster HS; Grothey A; Childs BH
J Clin Oncol; 2007 Sep; 25(25):4028-9. PubMed ID: 17664456
[No Abstract] [Full Text] [Related]
4. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
Cavaletti G
Oncologist; 2011; 16(12):1667-8. PubMed ID: 22128117
[TBL] [Abstract][Full Text] [Related]
5. The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.
Knijn N; Tol J; Koopman M; Werter MJ; Imholz AL; Valster FA; Mol L; Vincent AD; Teerenstra S; Punt CJ
Eur J Cancer; 2011 Feb; 47(3):369-74. PubMed ID: 21067912
[TBL] [Abstract][Full Text] [Related]
6. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
Khattak MA
Oncologist; 2011; 16(12):1780-3. PubMed ID: 22128115
[TBL] [Abstract][Full Text] [Related]
7. Role of calcium/ magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients.
Kurniali PC; Luo LG; Weitberg AB
Oncology (Williston Park); 2010 Mar; 24(3):289-92. PubMed ID: 20394142
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-related neurotoxicity: is chelation the solution?
Hoff PM
Nat Clin Pract Oncol; 2004 Dec; 1(2):78-9. PubMed ID: 16264824
[No Abstract] [Full Text] [Related]
9. New data question treatment for oxaliplatin neurotoxicity.
Wolf SL
Clin J Oncol Nurs; 2008 Feb; 12(1):14; author reply 14. PubMed ID: 18323035
[No Abstract] [Full Text] [Related]
10. Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy.
Gamelin L; Boisdron-Celle M; Morel A; Poirier AL; Berger V; Gamelin E; Tournigand C; de Gramont A
J Clin Oncol; 2008 Mar; 26(7):1188-9; author reply 1189-90. PubMed ID: 18309961
[No Abstract] [Full Text] [Related]
11. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
Grothey A; Nikcevich DA; Sloan JA; Kugler JW; Silberstein PT; Dentchev T; Wender DB; Novotny PJ; Chitaley U; Alberts SR; Loprinzi CL
J Clin Oncol; 2011 Feb; 29(4):421-7. PubMed ID: 21189381
[TBL] [Abstract][Full Text] [Related]
12. [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
Muto O; Ando H; Ono T; Itagaki H; Kobayashi Y; Onuki M; Akashi T; Tanaka Y; Hanaoka T
Gan To Kagaku Ryoho; 2007 Apr; 34(4):579-81. PubMed ID: 17431344
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature.
Ali BH
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):272-9. PubMed ID: 20050845
[TBL] [Abstract][Full Text] [Related]
14. Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis.
Wu Z; Ouyang J; He Z; Zhang S
Eur J Cancer; 2012 Aug; 48(12):1791-8. PubMed ID: 22542974
[TBL] [Abstract][Full Text] [Related]
15. [Oxaliplatin neurotoxicity].
Gamelin L; Boisdron-Celle M; Morel A; Gamelin E
Bull Cancer; 2006 Feb; 93 Suppl 1():S17-22. PubMed ID: 16491518
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].
Dong M; Xing PY; Liu P; Feng FY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):208-11. PubMed ID: 20450590
[TBL] [Abstract][Full Text] [Related]
17. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.
Screnci D; McKeage MJ
J Inorg Biochem; 1999 Oct; 77(1-2):105-10. PubMed ID: 10626361
[TBL] [Abstract][Full Text] [Related]
18. Calcium and magnesium for oxaliplatin-induced neuropathy.
Stansfield L
Am J Health Syst Pharm; 2014 Jun; 71(12):987-8. PubMed ID: 24865753
[No Abstract] [Full Text] [Related]
19. Acute oxaliplatin-induced peripheral-nerve hyperexcitability.
Schmelz R; Lersch C
J Clin Oncol; 2002 Aug; 20(16):3561-2; author reply 3562. PubMed ID: 12177120
[No Abstract] [Full Text] [Related]
20. Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
Chan A; Chiang J; Lew KY; Chay WY
J Clin Oncol; 2011 Jun; 29(16):e489; author reply e490-1. PubMed ID: 21482983
[No Abstract] [Full Text] [Related]
[Next] [New Search]
